Drugs / Betaglucin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03901690 | Aug 2019 → Mar 2020 | anogenital human papillomavirus infection | Centro de Investigaciones Medicas y Ensayos Clinicos Dr Italo Fabbri | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Betaglucin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03901690 ↗ |